According to the source, the general criteria for classifying drugs as OTC have been supplemented with special criteria for individual active substances.
GEROPHARM and OOO “R-Pharm” (member of R-Pharm Group of Companies) have announced a strategic partnership to localise the production of medicines for the treatment of socially significant diseases in Azerbaijan.
In the first quarter of 2025, the Zelenograd production site of Binnopharm Group increased its output of medicinal products for export by almost three times compared to the same period in 2024.
Vamotinib is about to be registered and put into civil circulation by Pharmasyntez, a Russian pharmaceutical company that aims to provide Russian patients with access to new and innovative medications.
Don’t miss your daily PharmProm news.
SUBSCRIBE free here!
Read more
Filtration and ventilation elements
CR-doors
Laminar flow devices
Furniture for cleanrooms
Panel construction, double-glazed windows
Pass-boxes
Read more
Read more
The quarterly review provides information on the inspection of manufacturers of veterinary medicines for compliance with the requirements of the GMP which is carried out by specialists of the Inspection Body of the FSBI "VGNKI".
In January–June 2023, Russian manufacturers produced 342.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), down 2.6% from the same period in 2022.
In January–May 2023, Russian manufacturers produced 282 billion rubles’ of pharmaceutical drugs (manufacturer’s prices, VAT included), down 5.8% from the same period in 2022.
In January–March 2023, the online sales or reservations of pharmacy products (pharmaceutical drugs and parapharmaceuticals) in Russia were 80.2 billion rubles (end-user prices, VAT included), up 2.3% from January–March 2022 (against 69.6% in Q1 2022, with its rush demand).